/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

J

Jean‐Yves Douillard

Integrated Oncology (United States)(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

383

Papers

33.3K

Citations

69

h-index

173

i10-index

Jean‐Yves Douillard is an academic researcher from Integrated Oncology (United States). The author has contributed to research in topics: Colorectal Cancer Treatments and Studies & Lung Cancer Treatments and Mutations & Cancer Treatment and Pharmacology. The author has an h-index of 69, co-authored 326 publications.

ORCID: 0000-0002-6540-7333

Research Topics

Colorectal Cancer Treatments and Studies Lung Cancer Treatments and Mutations Cancer Treatment and Pharmacology Gastric Cancer Management and Outcomes Lung Cancer Research Studies

Papers by this author

works

ESMO consensus guidelines for the management of patients with metastatic colorectal cancer

2016 · Annals of Oncology · 3,333 citations

https://doi.org/10.1093/annonc/mdw235

Eric Van Cutsem Andrés Cervantes René Adam Alberto Sobrero

ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making

2012 · Annals of Oncology · 1,505 citations

https://doi.org/10.1093/annonc/mds236

Hans‐Joachim Schmoll Eric Van Cutsem Alexander Stein Vincenzo Valentini

Impact of early tumour shrinkage and resection on outcomes in patients with wild-type RAS metastatic colorectal cancer

2015 · European Journal of Cancer · 82 citations

https://doi.org/10.1016/j.ejca.2015.03.026

Jean‐Yves Douillard Salvatore Siena Marc Peeters Reija Koukakis

Recent issues in first-line treatment of advanced non-small-cell lung cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology

2009 · Lung Cancer · 70 citations

https://doi.org/10.1016/j.lungcan.2009.11.018

Cesare Gridelli Andrea Ardizzoni Jean‐Yves Douillard Nasser H. Hanna

Analysis of patient-reported outcomes from the LUME-Lung 1 trial: A randomised, double-blind, placebo-controlled, Phase III study of second-line nintedanib in patients with advanced non-small cell lung cancer

2014 · European Journal of Cancer · 65 citations

https://doi.org/10.1016/j.ejca.2014.11.015

Silvia Novello R. Kaiser Anders Mellemgaard Jean‐Yves Douillard

Effect of Primary Tumor Location on Second- or Later-line Treatment Outcomes in Patients With RAS Wild-type Metastatic Colorectal Cancer and All Treatment Lines in Patients With RAS Mutations in Four Randomized Panitumumab Studies

2018 · Clinical Colorectal Cancer · 50 citations

https://doi.org/10.1016/j.clcc.2018.03.005

Nele Boeckx Reija Koukakis Ken Op de Beeck Christian Rolfo

Research topics

topics

Colorectal Cancer Treatments and Studies

Lung Cancer Treatments and Mutations

Cancer Treatment and Pharmacology

Gastric Cancer Management and Outcomes

Lung Cancer Research Studies

Chat about Author

Papers

Chat

Click to start Chat